Pablo Alexis Doreski

Statistics

Publications

Citations

665

H-Index

Active since

2016

Affiliations

Moderna Therapeutics (United States)(Current)

National Center for Global Health and Medicine

Johns Hopkins University

Newcastle upon Tyne Hospitals NHS Foundation Trust

Hospital Privado

Pablo Alexis Doreski is an author at Moderna Therapeutics (United States) specializing in infectious diseases, veterinary medicine, and pharmacotherapy.

Publications per year

2016–2024

Publications

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

Eleanor Wilson, Jaya Goswami, Abdullah H Baqui et al. · New England Journal of Medicine · 2023 · 453 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 101 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

Jatin Patel, Damon Bass, Albertus Beishuizen et al. · European Respiratory Journal · 2022 · 42 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

Jaya Goswami, Abdullah H Baqui, Pablo Alexis Doreski et al. · The Journal of Infectious Diseases · 2024 · 41 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program

Oscar Salva, Pablo Alexis Doreski, Celia Sara Giler et al. · Infectious Diseases and Therapy · 2021 · 16 citations · Full text

Pharmacy, Pharmacotherapy, Respiratory Therapy +17

1–5 of 6